Bar Admissions

  • District of Columbia
  • Maryland


  • J.D., cum laude, Harvard Law School, 1989
  • B.A., Pennsylvania State University, 1985

Judicial Clerkships

  • Honorable Francis D. Murnaghan, Jr., U.S. Court of Appeals for the Fourth Circuit, 1989 - 1990
T +1 410.244.7679
F +1 410.244.7742

Dino S. Sangiamo


Dino Sangiamo litigates civil cases in state and federal courts across the United States. A substantial portion of his practice consists of litigating on behalf of the pharmaceutical industry, although it includes other commercial clients as well.

In the pharmaceutical setting, Dino has represented manufacturers in a wide variety of vaccine and drug disputes. His products liability practice has included serving as lead counsel in all aspects of individual cases from start to finish; determining nationwide strategy in mass tort litigation; developing and implementing legal, factual, and scientific defenses for use across cases; coordinating with other industry defendants; and managing company discovery, including defending company officials at deposition and developing approaches to large-scale document discovery. He has also argued important cases of first impression before the appellate courts. Beyond products liability, Dino has handled research fraud matters in various contexts including cases involving the False Claims Act. He also has assisted in proceedings before congressional committees and consulted on public relations activities and other client business initiatives. Dino's experience with numerous legal aspects of the vaccine industry also includes familiarity with national vaccine legislation and implications for industry of proceedings in Vaccine Court, where he has argued motions on behalf of a vaccine manufacturer. He has also assisted in developing regulatory compliance programs. Finally, Dino has served in a local counsel role in vaccine and medical device cases.

In other commercial settings, Dino has handled a variety of litigation matters including both arbitrations and lawsuits. In recent years, these have consisted of several matters in the context of cutting-edge medical research and disputes involving hospitals and hospital systems. 

Significant Matters


Dino's pharmaceutical practice in recent years has included the following:
  • Representing a vaccine manufacturer in a whistleblower lawsuit alleging fraudulent conduct in the conduct of a clinical trial and misstatement of a product’s efficacy.
  • Representing the manufacturer of an adult vaccine in a lawsuit alleging brain injury resulting from vaccination.
  • Representing the manufacturer of an anti-epileptic drug in nationwide litigation concerning alleged birth defects from maternal use of the product.
  • Representing the manufacturer of an anesthetic in nationwide litigation concerning allegations of injury from use of the product in a continuous infusion “pain pump.”
  • Representing a vaccine manufacturer in nationwide litigation concerning the allegation that a preservative in vaccines causes autism.
  • Representing a manufacturer of a cholesterol-reducing drug in nationwide litigation concerning allegations of muscle and psychological injuries.
  • Representing a vaccine manufacturer as intervenor in defense of a suit filed against the FDA for release of data previously submitted by the manufacturer to the government.
  • Representing a vaccine manufacturer defending against efforts to issue subpoenas for manufacturer documents in Vaccine Court.
  • Representing a vaccine manufacturer in protecting its confidential commercial information and trade secrets contained in documents produced by the government in proceedings in Vaccine Court.
  • Representing a vaccine manufacturer in responding to congressional inquiries.

 Dino's other commercial practice in recent years has also included the following:
  • Representing a medical research institution in connection with claims of research fraud.
  • Representing a hospital system in an outsourcing contract dispute with a pharmaceutical repackager.
  • Representing a hospital in a dispute over construction and installation of a hyperbaric chamber.
  • Representing an organ bank in a potential dispute over termination of a contract with an organ supplier.